The Management Board of Nestmedic S.A. with its registered office in Warsaw (hereinafter the “Company”, the “Issuer”) hereby submits, attached hereto, the separate and consolidated quarterly report for Q3 2023.
Legal basis:
§ 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”
Legal basis:
§ 5 sec. 1 item 1 of Appendix No. 3 to the Rules of the Alternative Trading System “Current and Periodic Information Provided in the Alternative Trading System on the NewConnect Market”
- Jacek Gnich – President of the Management Board
- Beata Turlejska – Vice-President of the Management Board
